Law Offices of Gary Martin Hays & Associates
P.C.
75 Ponce De Leon Ave NE Ste 101
Atlanta,
GA 30308(470) 294-1674
www.garymartinhays.com
Litigation Daily | Conversation
By Ross Todd | June 4, 2024
Jason Sheasby and Lisa Glasser of Irell & Manella just handled three trials which took them from Marshall, Texas, to Los Angeles and back again.
By Alex Anteau | June 3, 2024
The plaintiff contends Audible had notice that it was infringing on its patents more than 10 years ago.
By Marianna Wharry | May 28, 2024
Pfizer recently filed seven lawsuits in federal court seeking to enjoin multiple multinational pharmaceutical companies from selling a generic version of its medication, Nurtec, which is used to prevent and treat migraines.
By Kat Black | May 28, 2024
Access Optical Networks has accused Seagate of stealing confidential information to advance the research and development of its own next-generation mass data storage technology.
By Adolfo Pesquera | May 28, 2024
The judge ordered unredacted versions of his opinion go to the chief disciplinary counsel for the New York and California state bars, "in light of the indefensible conduct" of the attorneys involved in the Samsung patent case.
By Avalon Zoppo | May 24, 2024
"I think there'll be more (design patent rejections), but I don't think this is going to be some sort of sea change," said Finnegan Henderson partner Elizabeth Ferrill.
By Adolfo Pesquera | May 24, 2024
The verdict marks the law firms' second win on behalf of Netlist, following a recent $303 million patent infringement verdict against Samsung, McKool Smith announced.
Connecticut Law Tribune | News
By Emily Cousins | May 22, 2024
"Teva stifled would-be generic competitors to QVAR because the drug laws do not allow for generic substitution of a given drug-device combination unless the generic is approved for that specific drug-device combination," the complaint alleged.
By Fredrick Tsang, Antonia Sequeira and Carl Morales | May 8, 2024
This article explores the benefits and risks of AI-driven drug discovery from the legal perspective. Since the law governing IP rights in AI-driven drug discovery is still in its infant state, any future legal development is likely to have significant implications in many areas.
New York Law Journal | Analysis
By Catherine Nyarady and Crystal Parker | May 7, 2024
On April 15, 2024, the U.S. Court of Appeals for the Fourth Circuit affirmed a district court decision denying trademark registration to TBL Licensing LLC for its Timberland boots.
Presented by BigVoodoo
Celebrating achievement, excellence, and innovation in the legal profession in the UK.
Join the industry's top owners, investors, developers, brokers and financiers for the real estate healthcare event of the year!
This event shines a spotlight on how individuals and firms are changing the investment advisory industry where it matters most.
Role TitleAssociate General Counsel, Global EmploymentGrade F13Reporting ToSenior Legal Counsel, Global EmploymentProgram/Tool/ Department/U...
Ryan & Conlon, LLP, is a boutique firm specializing in insurance defense. We are a small eclectic practice with a busy and fast paced en...
